CRVL CorVel releases Q1 2026 earnings shares rise 029 percent in mild positive investor reaction ETHE ETHE Institutional Crypto Adoption Accelerates As Regulatory Clarity Unlocks Mainstream Access Why Nasus Pharma NSRX looks solid from every angle Investors Pile In 20260508 Why investors are rethinking Laser LASE Rallies Strongly 20260506